Bellevue-based Light Sciences Oncology has scored $23.35M in a credit facility, according to a regulatory filing from the firm Thursday. According to the filing, the firm received $23,347,833 as part of a credit facility, which came from 17 investors. The deal also includes $11.7M in warrant coverage. No details on the funding have been announced by Light Sciences, which is developing treatments for solid tumors and benign neoplasms.